Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-25-096923
Filing Date
2025-07-18
Accepted
2025-07-18 16:08:05
Documents
10
Period of Report
2024-12-20
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K/A fblg-20241220.htm   iXBRL 8-K/A 43731
  Complete submission text file 0000950170-25-096923.txt   159259

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fblg-20241220.xsd EX-101.SCH 26927
12 EXTRACTED XBRL INSTANCE DOCUMENT fblg-20241220_htm.xml XML 6444
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41934 | Film No.: 251134595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)